Stay updated on Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial
Sign up to get notified when there's something new on the Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial page.

Latest updates to the Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.5.2 was added to the history and v3.5.0 was removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedAddition of Revision: v3.5.0 and deletion of Revision: v3.4.3 are shown in the record history. The update indicates a page software/version change rather than a change to study details.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2 in the page history.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded a new revision entry v3.4.2 to the study history. Older revision v3.4.1 and a site-wide funding notice were removed.SummaryDifference0.8%

- Check82 days agoChange DetectedMinor history updates: a site-wide funding notice was added and the software version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check89 days agoChange DetectedIntroduced a glossary toggle and color-coded change highlights (green for additions, red for deletions) with an updated revision label (Revision: v3.4.0). The previous revision label (v3.3.4) and the No FEAR Act data entry were removed.SummaryDifference1.0%

Stay in the know with updates to Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial page.